How Innovations and Regulations Impact the Future of IVF Treatment


Dr. Shivani Sachdev Gour, Director of SCI Healthcare, discusses IVF. India's young population has driven up demand, with over 1 in 10 couples facing conception issues. “While surrogacy for international patients is banned, many still come from SAARC and African countries for IVF. The industry has become more organized, with new centers and corporate IVF chains,” says Dr Shivani Sachdev Gour.

“India currently conducts an average of 200,000 to 250,000 IVF cycles per year, with projections indicating this could rise to 500,000 to 600,000 cycles annually."

She also predicts that the market will likely see the entry of new players as well as numerous mergers and acquisitions. Smaller local players may be acquired by larger companies, a trend similar to that seen in the hospital sector, which will lead to greater transparency and higher quality treatments for patients. She notes that major brands are aiming to expand their reach to tier 2 and tier 3 cities.

Comments